Skip to Content

Lincomycin 300 (Bimeda)

This page contains information on Lincomycin 300 (Bimeda) for veterinary use.
The information provided typically includes the following:
  • Lincomycin 300 (Bimeda) Indications
  • Warnings and cautions for Lincomycin 300 (Bimeda)
  • Direction and dosage information for Lincomycin 300 (Bimeda)

Lincomycin 300 (Bimeda)

This treatment applies to the following species:
Manufacturer: Aspen

Lincomycin Injection, USP

300 mg

Swine Antibiotic

For Animal Use Only

Not for Human Use

Keep Out of Reach of Children

For use in swine weighing 300 pounds or more.

For Intramuscular Use in Swine Only

Lincomycin 300 contains lincomycin hydrochloride, an antibiotic produced by Streptomyces lincolnensis var. lincolnensis which is chemically distinct from all other clinically available antibiotics and is a white crystalline solid.

INDICATIONS FOR SWINE:

Lincomycin 300 is indicated for the treatment of infectious forms of arthritis caused by organisms sensitive to its activity. This includes most of the organisms responsible for the various infectious arthritides in swine, such as staphylococci, streptococci, Erysipelothrix and Mycoplasma spp.

It is also indicated for the treatment of mycoplasma pneumonia.

Contraindications

As with all drugs, use of Lincomycin 300 is contraindicated in animals previously found to be hypersensitive to the drug.

Residue Warning: Swine intended for human consumption should not be slaughtered within 48 hours of latest treatment.

Human Warnings: Not for human use. Keep out of reach of children.

Lincomycin 300 (Bimeda) Caution

If no improvement is noted within 48 hours, consult a veterinarian.

Adverse Reactions

The intramuscular administration to swine may cause a transient diarrhea or loose stools. Although this effect has rarely been reported, one must be alert to the possibility that it may occur. Should this occur, it is important that the necessary steps be taken to prevent the effects of dehydration.

Dosage and Administration

For arthritis or mycoplasma pneumonia - 5 mg/lb body weight intramuscularly once daily for three to seven days as needed. One mL per 60 lb body weight will provide 5 mg/lb.

For optimal results, initiate treatment as soon as possible.

As with any multi-dose vial, practice aseptic techniques in withdrawing each dose. Adequately clean and disinfect the vial closure prior to entry with a sterile needle and syringe. No vial closure should be entered more than 20 times.

Each mL contains:

Lincomycin hydrochloride equivalent to lincomycin 300 mg; also benzyl alcohol 9.45 mg added as preservative.

How Supplied

100 mL multiple dose vials.

Store at controlled room temperature 20° to 25° C (68° to 77° F) [see USP]. KEEP FROM FREEZING.

ANADA #200-368, Approved by FDA

For Intramuscular Use in Swine.

Restricted Drug (California) - Use Only as Directed. For Use in Animals Only.

Manufactured for: Aspen Veterinary Resources,® Ltd., Liberty, MO 64068, USA

Manufactured by: Bimeda-MTC Animal Health Inc., Cambridge, ON Canada N3C 2W4

NET CONTENTS:

Product No.

 

100 mL (3.3 fl oz)

8LIN004

A215B 03/12

NAC No.: 14752660

ASPEN VETERINARY RESOURCES, LTD.
3155 W. HEARTLAND DRIVE, LIBERTY, MO, 64068
Telephone:   816-415-4324
Fax:   816-415-4314
Website:   www.aspenveterinaryresources.com
Every effort has been made to ensure the accuracy of the Lincomycin 300 (Bimeda) information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2016 North American Compendiums. Updated: 2016-08-21

Hide